Lung Non-Small Cell Carcinoma — Trials

Lung Non-Small Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

6,745 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,749
Recruiting: 926
Ph III recruiting: 138
Growth YoY: +3.1%
Industry share: 44%
Top sponsor: AstraZeneca
Termination share: 39%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,044)

clinicaltrialsPublishedShowing 51–100 of 322 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07090499	A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors	recruiting	Phase 1	540	PfizerINDUSTRY	6	Sep 4, 2026	clinicaltrials
NCT07361562	A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors	recruiting	Phase 1	100	Cogent Biosciences, Inc.INDUSTRY	1	Sep 4, 2026	clinicaltrials
NCT07613723